Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
Horm Metab Res. 2016 Jun;48(6):349-58. doi: 10.1055/s-0042-107792. Epub 2016 May 20.
Horm Metab Res. 2016.
PMID: 27203411
Review.